Why has ConnectiveRx's CoPay Assistance Program seen a 15% drop in patient enrollment over the past quarter?

Introduction

ConnectiveRx's CoPay Assistance Program has experienced a 15% drop in patient enrollment over the past quarter, signaling a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root cause of this decline, considering both short-term and long-term implications for the program's success.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Has this 15% drop been compared to the same quarter last year?

Why it matters: Seasonal variations could explain the enrollment decline. Expected answer: Yes, it has been compared, and the drop is still significant. Impact on approach: If seasonal, we'd focus on year-over-year trends rather than quarter-over-quarter.

• Considering potential changes in the program itself, have there been any recent modifications to the eligibility criteria or application process?

Why it matters: Changes in program structure could directly impact enrollment rates. Expected answer: No major changes have been implemented recently. Impact on approach: If changes were made, we'd analyze their specific impact on enrollment.

• Thinking about external factors, has there been any shift in the competitive landscape or introduction of new assistance programs?

Why it matters: Competitive pressures could be drawing patients away from ConnectiveRx's program. Expected answer: There have been some new entrants, but nothing major. Impact on approach: If significant competition exists, we'd need to assess our program's comparative value proposition.

• Considering data integrity, has there been any change in how enrollment is tracked or reported?

Why it matters: Ensures we're comparing apples to apples in our metrics. Expected answer: No changes in tracking or reporting methods. Impact on approach: If changes occurred, we'd need to recalibrate our analysis based on the new methodology.